S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Allscripts Healthcare Solutions Stock Price, News & Analysis (NASDAQ:MDRX)

$11.14
+0.22 (+2.01 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$10.88
Now: $11.14
$11.18
50-Day Range
$8.90
MA: $10.38
$11.13
52-Week Range
$8.54
Now: $11.14
$13.49
Volume1.01 million shs
Average Volume1.94 million shs
Market Capitalization$1.86 billion
P/E Ratio20.25
Dividend YieldN/A
Beta1.39
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. Read More…

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDRX
CUSIP01988P10
Phone800-334-8534

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.75 billion
Cash Flow$1.78 per share
Book Value$9.05 per share

Profitability

Net Income$412.33 million

Miscellaneous

Employees9,500
Market Cap$1.86 billion
Next Earnings Date11/4/2019 (Confirmed)
OptionableOptionable

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.


Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its board has approved a share repurchase plan on Thursday, August 2nd 2018, which permits the company to buyback $250,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 11.3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board of directors believes its shares are undervalued.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, August, 8th. The software maker reported $0.17 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.16 by $0.01. The software maker earned $444.50 million during the quarter, compared to analyst estimates of $449.03 million. Allscripts Healthcare Solutions had a return on equity of 6.17% and a net margin of 9.85%. Allscripts Healthcare Solutions's revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.18 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Allscripts Healthcare Solutions.

How can I listen to Allscripts Healthcare Solutions' earnings call?

Allscripts Healthcare Solutions will be holding an earnings conference call on Monday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY19 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of $0.65-0.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.68.

What price target have analysts set for MDRX?

10 Wall Street analysts have issued 12 month price objectives for Allscripts Healthcare Solutions' stock. Their predictions range from $10.00 to $15.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $12.19 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019)
  • 2. According to Zacks Investment Research, "Allscripts continues to gain from its Software, Delivery, Support and Maintenance units, which delivered solid growth in the last couple of quarters. Significant growth in bookings also buoys optimism. The company’s growth in revenue cycle services along with the recently-closed acquisition of HealthGrid is likely to boost its FollowMyHealth patient engagement platform. Apart from these, management is optimistic about the collaboration with Microsoft made in the recent past. On the flip side, the company’s core Client Services unit has reported dismal performance in recent times. Also, Allscripts saw significant margin contraction in the last reported quarter. The company is exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (4/24/2019)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

Media stories about MDRX stock have trended somewhat negative recently, InfoTrie reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave media coverage about the software maker a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Allscripts Healthcare Solutions.

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a drop in short interest in the month of September. As of September 15th, there was short interest totalling 21,690,000 shares, a drop of 5.5% from the August 15th total of 22,960,000 shares. Based on an average daily trading volume, of 1,770,000 shares, the days-to-cover ratio is currently 12.3 days. Currently, 13.3% of the company's stock are sold short. View Allscripts Healthcare Solutions' Current Options Chain.

Who are some of Allscripts Healthcare Solutions' key competitors?

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Starbucks (SBUX), Walgreens Boots Alliance (WBA), Activision Blizzard (ATVI), AK Steel (AKS), Oasis Petroleum (OAS), Twitter (TWTR), American Airlines Group (AAL) and Autodesk (ADSK).

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 61)
  • Mr. Richard J. Poulton, Pres (Age 54)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.83%), Hennessy Advisors Inc. (0.58%), Smith Graham & Co. Investment Advisors LP (0.37%), Zeke Capital Advisors LLC (0.08%), Meeder Asset Management Inc. (0.04%) and Pacer Advisors Inc. (0.04%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., Clear Street Markets LLC, Pacer Advisors Inc. and Meeder Asset Management Inc.. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Zeke Capital Advisors LLC, Peregrine Capital Management LLC, State of Alaska Department of Revenue and Robeco Institutional Asset Management B.V.. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $11.14.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $1.86 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.View Additional Information About Allscripts Healthcare Solutions.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  587 (Vote Outperform)
Underperform Votes:  613 (Vote Underperform)
Total Votes:  1,200
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel